NRIX Stock-Based Compensation
Nurix Therapeutics Inc · Stock-Based Compensation
NRIX Stock-Based Compensation
Latest reported$40.66Mperiod ending
NRIX Stock-Based Comp ($431.00K → $40.66M)
Annual stock-based compensation
High-resolution chart · PNG
NRIX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 37,965,000 | |
| 33,929,000 | |
| 33,673,000 | |
| 28,131,000 | |
| 15,800,000 | |
| 4,301,000 | |
| 510,000 | |
| 431,000 |